£80.84

MDPI AG Non-Alcoholic Fatty Liver Disease Research 2016

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£81 today · previous high £81 · all-time low £78

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days • 91 data points

Historical
Generating forecast...
£80.84 £77.56 £78.28 £78.99 £79.71 £80.42 £81.14 08 March 2026 30 March 2026 22 April 2026 14 May 2026 06 June 2026

Price Distribution

Price distribution over 91 days • 2 price levels

Days at Price
Current Price
80 days 11 days · current 0 20 40 60 80 £78 £81 Days at Price

Price Analysis

Most common price: £78 (80 days, 87.9%)

Price range: £78 - £81

Price levels: 2 different prices over 91 days

Description

This new book entitled "Non-Alcoholic Fatty Liver Disease Research 2016" covers a selection of recent research topics and current review articles in the field of nonalcoholic fatty liver disease (NAFLD) that have been recently published in a monographic Special Issue of the International Journal of Molecular Sciences (IJMS) journal. NAFLD is an “umbrella” definition that encompasses a spectrum of histopathological liver changes ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) with/without fibrosis, “cryptogenic” cirrhosis and hepatocellular carcinoma. NAFLD has become one of the most common forms of chronic liver disease worldwide and its prevalence is expected to continue rising. It is now becoming increasingly clear that the clinical and economic burden of NAFLD does not only affect the liver, but also affects the risk of developing cardiovascular disease, type 2 diabetes mellitus, colo-rectal neoplasms, chronic kidney disease and other extra-hepatic diseases that have a considerable impact on health-care expenditures. Against this background, further research is needed to better understand the natural history, and the molecular pathogenesis of NAFLD, as well as to elucidate the underlying mechanisms by which NAFLD contributes to the increased cardiometabolic risk, and to disclose novel and effective treatment strategies for this increasingly prevalent and burdensome disease. Some of the leading international researchers in this area expressed a willingness to contribute to this book providing an updated, state-of-the-art view on the aforementioned topics, and also suggesting novel research avenues for NAFLD.

Product Specifications

Brand
MDPI AG
Format
paperback
Domain
Amazon UK
Release Date
27 August 2018
Listed Since
30 August 2018

Barcode

No barcode data available

Similar Products You Might Like

Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside
84% match

Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside

Springer

£62.75 05 Jun 2026
Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development
82% match

Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development

Springer

£111.22 24 May 2026
Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma
82% match

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

Springer

£77.75 22 May 2026
Acute and Chronic Liver Diseases: Molecular Biology and Clinics: 87 (Falk Symposium, 87)
80% match

Acute and Chronic Liver Diseases: Molecular Biology and Clinics: 87 (Falk Symposium, 87)

Springer

£24.00 05 Jun 2026
Steatohepatitis (NASH and ASH): 121 (Falk Symposium, 121)
80% match

Steatohepatitis (NASH and ASH): 121 (Falk Symposium, 121)

Springer

£142.11 05 Jun 2026
Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)
80% match

Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)

Springer

£71.94 06 Jun 2026
Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune: 157 (Falk Symposium, 157)
80% match

Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune: 157 (Falk Symposium, 157)

Springer

£45.55 19 May 2026
Liver Cirrhosis: Causes, Diagnosis & Treatment (Hepatology Research and Clinical Developments)
79% match

Liver Cirrhosis: Causes, Diagnosis & Treatment (Hepatology Research and Clinical Developments)

£147.99 05 Jun 2026
Studies on Hepatic Disorders (Oxidative Stress in Applied Basic Research and Clinical Practice)
79% match

Studies on Hepatic Disorders (Oxidative Stress in Applied Basic Research and Clinical Practice)

Humana

£108.75 25 May 2026
Bile Acids and Their Receptors: 256 (Handbook of Experimental Pharmacology, 256)
79% match

Bile Acids and Their Receptors: 256 (Handbook of Experimental Pharmacology, 256)

Springer

£83.01 24 May 2026
Non-Alcoholic Fatty Liver Disease: Diagnosis and Treatment
78% match

Non-Alcoholic Fatty Liver Disease: Diagnosis and Treatment

£121.20 26 May 2026
Liver Cirrhosis: From Pathophysiology to Disease Management: 162 (Falk Symposium, 162)
78% match

Liver Cirrhosis: From Pathophysiology to Disease Management: 162 (Falk Symposium, 162)

Springer

£76.52 05 Jun 2026
Hepadnaviruses: Molecular Biology and Pathogenesis: 168 (Current Topics in Microbiology and Immunology, 168)
78% match

Hepadnaviruses: Molecular Biology and Pathogenesis: 168 (Current Topics in Microbiology and Immunology, 168)

Springer

£74.12 31 May 2026
77% match

Advanced Ultrasound with Imaging Correlations of Diffuse Liver Diseases

Academic Press

£137.99 19 May 2026
Non-Neoplastic Liver Pathology: A Pathologist’s Survival Guide
77% match

Non-Neoplastic Liver Pathology: A Pathologist’s Survival Guide

Springer

£91.92 05 Jun 2026
Hepatitis B Virus and Liver Disease
77% match

Hepatitis B Virus and Liver Disease

Springer

£89.12 05 Jun 2026
Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome
77% match

Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome

Springer

£107.98 31 May 2026
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics: 824 (Advances in Experimental Medicine and Biology, 824)
77% match

Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics: 824 (Advances in Experimental Medicine and Biology, 824)

Springer

£87.64 01 Jun 2026
Molecular Basis of Health and Disease
76% match

Molecular Basis of Health and Disease

Springer

£110.00 21 May 2026
Hepatitis Prevention and Treatment (Milestones in Drug Therapy)
76% match

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Birkhauser

£108.16 24 May 2026
Hepatitis Prevention and Treatment (Milestones in Drug Therapy)
76% match

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Birkhauser

£117.20 23 May 2026
Disorders of Lipid Metabolism
76% match

Disorders of Lipid Metabolism

Springer

£73.85 18 May 2026
Drug-Induced Liver Toxicity (Methods in Pharmacology and Toxicology)
76% match

Drug-Induced Liver Toxicity (Methods in Pharmacology and Toxicology)

Humana

£88.30 04 Jun 2026
Nanotoxicity: Methods and Protocols: 1894 (Methods in Molecular Biology, 1894)
76% match

Nanotoxicity: Methods and Protocols: 1894 (Methods in Molecular Biology, 1894)

Humana

£104.18 31 May 2026